69 related articles for article (PubMed ID: 15090179)
1. Development of an assay suitable for high-throughput screening to measure matrix metalloprotease activity.
Peppard J; Pham Q; Clark A; Farley D; Sakane Y; Graves R; George J; Norey C
Assay Drug Dev Technol; 2003 Jun; 1(3):425-33. PubMed ID: 15090179
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an imaging platform during the development of a FRET protease assay.
George J; Teear ML; Norey CG; Burns DD
J Biomol Screen; 2003 Feb; 8(1):72-80. PubMed ID: 12855000
[TBL] [Abstract][Full Text] [Related]
3. A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Bickett DM; Green MD; Berman J; Dezube M; Howe AS; Brown PJ; Roth JT; McGeehan GM
Anal Biochem; 1993 Jul; 212(1):58-64. PubMed ID: 8368516
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
5. Use of a multiple-enzyme/multiple-reagent assay system to quantify activity levels in samples containing mixtures of matrix metalloproteinases.
Rasmussen FH; Yeung N; Kiefer L; Murphy G; Lopez-Otin C; Vitek MP; Moss ML
Biochemistry; 2004 Mar; 43(11):2987-95. PubMed ID: 15023050
[TBL] [Abstract][Full Text] [Related]
6. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
7. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
Golla R; Seethala R
J Biomol Screen; 2002 Dec; 7(6):515-25. PubMed ID: 14599349
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.
O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T
Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
[TBL] [Abstract][Full Text] [Related]
10. Determination of matrix metalloproteinase activity using biotinylated gelatin.
Ratnikov B; Deryugina E; Leng J; Marchenko G; Dembrow D; Strongin A
Anal Biochem; 2000 Nov; 286(1):149-55. PubMed ID: 11038285
[TBL] [Abstract][Full Text] [Related]
11. Extending matrix-assisted laser desorption/ionization triple quadrupole mass spectrometry enzyme screening assays to targets with small molecule substrates.
Rathore R; Corr JJ; Lebre DT; Seibel WL; Greis KD
Rapid Commun Mass Spectrom; 2009 Oct; 23(20):3293-300. PubMed ID: 19757451
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of inhibition of purified bovine neutrophil matrix metalloproteinase 9 by low-molecular-weight inhibitors.
Bannikov GA; Lakritz J; Premanandan C; Mattoon JS; Abrahamsen EJ
Am J Vet Res; 2009 May; 70(5):633-9. PubMed ID: 19405903
[TBL] [Abstract][Full Text] [Related]
13. pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B.
Fasciglione GF; Marini S; D'Alessio S; Politi V; Coletta M
Biophys J; 2000 Oct; 79(4):2138-49. PubMed ID: 11023917
[TBL] [Abstract][Full Text] [Related]
14. A protease inhibitor discovery method using fluorescence correlation spectroscopy with position-specific labeled protein substrates.
Nakata H; Ohtsuki T; Sisido M
Anal Biochem; 2009 Jul; 390(2):121-5. PubMed ID: 19394304
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of a metalloprotease of the pappalysin family revealed by an inhibitor and a product complex.
García-Castellanos R; Tallant C; Marrero A; Solà M; Baumann U; Gomis-Rüth FX
Arch Biochem Biophys; 2007 Jan; 457(1):57-72. PubMed ID: 17097044
[TBL] [Abstract][Full Text] [Related]
16. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-throughput robotic fluorescence-based assay for HsEg5 inhibitor screening.
Zhang B; Senator D; Wilson CJ; Ng SC
Anal Biochem; 2005 Oct; 345(2):326-35. PubMed ID: 16125662
[TBL] [Abstract][Full Text] [Related]
18. [High-throughput screening of human soluble epoxide hydrolase inhibitors].
Wang SB; Guo J; Yu XM; Du GH
Yao Xue Xue Bao; 2010 Nov; 45(11):1367-72. PubMed ID: 21361036
[TBL] [Abstract][Full Text] [Related]
19. [Matrix metalloproteinases and their biological functions].
Solov'eva NI
Bioorg Khim; 1998 Apr; 24(4):245-55. PubMed ID: 9612566
[TBL] [Abstract][Full Text] [Related]
20. In-capillary screening of matrix metalloproteinase inhibitors by electrophoretically mediated microanalysis with fluorescence detection.
Hai X; Wang X; El-Attug M; Adams E; Hoogmartens J; Van Schepdael A
Anal Chem; 2011 Jan; 83(1):425-30. PubMed ID: 21142123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
